Option chain shows key data for M&A Research Institute's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for M&A Research Institute.

M&A Research Institute (OTC:MAARF) Stock, Option Chain

M&A Research Institute Holdings Inc is a technology-based M&A brokerage company.

M&A RESH INST HLDGS INC by M&A RESH INST HLDGS INC.

M&A Research Institute Holdings Inc

WIIM

UPWK

Upwork shares are trading higher after the company reported better-than-expected Q4 financial results. Also, multiple firms raised their respective price targets on the stock.

Investors love dividend stocks, and it's easy to see why. They provide a reliable income stream while offering the potential for capital appreciation. Some investors focus on total returns, while others prioritize passive income, or even a mix of both. For those looking for a hassle-free approach, <a href="https://www.benzinga.com/etfs">dividend-focused ETFs</a> are an excellent choice.
ETFs yielding dividends simplify the process by offering instant diversification, typically at a lower cost than actively managed funds. They are easy to buy and sell, and many are managed by well-known asset managers. If you're looking to test some dividend-generating stocks but can&#8217;t decide which one to invest in, here are five high-yield ETFs that are gaining investor interest—some of them ranking among the most searched names on Benzinga.
Also Read: <a href="https://www.benzinga.com/top-stories/25/02/43433458/yieldmax-rolls-out-new-etf-for-investors-to-tap-into-carvanas-rally-and-generate-income">YieldMax Rolls Out New ETF For Investors To Tap Into Carvana&#8217;s Rally And Generate Income</a>
<ul>
<li>The YieldMax Ultra Option Income Strategy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ULTY#NYSE">ULTY</a>) is designed to maximize yield by implementing an options-based income strategy. This ETF invests in a diversified set of options contracts, aiming to generate high monthly income while managing risk exposure. It's an attractive pick for income-focused investors looking for steady payouts. The Distribution Rate, which represents the projected annual return based on the latest declared distribution, including option income and dividends, is 85.01%. The net expense ratio is 1.14%.</li>
</ul>
<ul>
<li>The YieldMax MSTR Option Income Strategy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSTY#NYSE">MSTY</a>) provides exposure to MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) while implementing an options strategy to boost income. Given MicroStrategy's increasing involvement in Bitcoin holdings, this ETF is popular among investors seeking crypto-adjacent income opportunities. The ETF has a distribution rate of 98.03%, and an expense ratio of 0.99%.</li>
</ul>
<ul>
<li>The YieldMax Universe Fund of Option Income ETFs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YMAX#NYSE">YMAX</a>) is a fund-of-funds that invests in a portfolio of high-yielding option income ETFs. This means investors get access to multiple high-income strategies in a single fund. Its distribution rate is 47.11% and it carries an expense ratio of 1.28%.</li>
</ul>
<ul>
<li>The YieldMax NVDA Option Income Strategy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVDY#NYSE">NVDY</a>) is tailor-made for investors who want exposure to Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) while generating additional income through options. Nvidia has been a buzzing stock among tech investors, and this ETF allows them to benefit from both the company's growth potential and option-generated yield. The ETF has a distribution rate of 52.44% and carries an expense ratio of 1.01%.</li>
</ul>
For those who are bullish on Bitcoin but also want steady income, the YieldMax Bitcoin Option Income Strategy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YBIT#NYSE">YBIT</a>) is an interesting choice. It uses options to generate yield while maintaining exposure to Bitcoin's price movements, making it an intriguing pick for crypto-savvy income investors. The distribution rate is 84.66% and the expense ratio is 0.99%.
Dividend ETFs provide an easy and cost-effective way to generate passive income while diversifying across multiple stocks or assets. The YieldMax family of ETFs, in particular, has captured significant attention due to their innovative options-based income strategies. With the growing popularity of dividend ETFs, these high-yield options are definitely worth keeping an eye on.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/new-etfs/25/02/43703434/new-leveraged-etfs-let-traders-bet-big-on-dell-intel-qualcomm">New Leveraged ETFs Let Traders Bet Big On Dell, Intel, Qualcomm</a></li>
</ul>
Photo: Shutterstock

Specialty ETFs

ETFs

MSTR

Tidal Trust II YieldMax MSTR Option Income Strategy ETF

MSTY

NVDA

NVDY

ULTY

YBIT

YMAX

5 High-Yield Dividend ETFs By YieldMax That Investors Are Talking About

Biotech

General

IBRX

ImmunityBio Announces UK MHRA Accepted Marketing Authorization Application For ANKTIVA

Shares of HubSpot Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBS#NYSE">HUBS</a>) were climbing in early trading on Thursday, after the company reported <a href="https://www.benzinga.com/news/earnings/25/02/43678257/hubspot-shares-climb-after-solid-q4-report-eps-beat-revenues-beat">upbeat fourth-quarter results</a>.
The company reported its quarterly results amid <a href="https://www.benzinga.com/earnings">positive earnings season</a>. Here are some key analyst takeaways.
Piper Sandler On HubSpot
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/586e4055351b9b00018beeab/brent-bracelin">Analyst Brent Bracelin</a> maintained a Neutral rating, while raising the price target from $640 to $808.
HubSpot reported "solid" results, with an improvement in the demand environment, Bracelin said. The company's revenues came in $30 million higher than estimates, he added.
Management indicated that AI drive "higher multi-cloud attach rates," with more than 50% unit attach-rate of Content Hub to Marketing Hub suggesting that "new AI products are contributing to improving optimism," the analyst stated. This highlights "the potential for AI to reinforce the value proposition of multi-cloud platforms," he further wrote.
Needham On HubSpot
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/602e465f5864de0001ada5b0/joshua-reilly">Analyst Joshua Reilly</a> reaffirmed a Buy rating, while lifting the price target from $730 to $900.
HubSpot reported fourth-quarter revenues and earnings of $703.2 million and $2.32 per share, respectively, Reilly said. Total revenue grew 20.8% year-on-year, driven by subscription revenue growth of 20.5% and professional services growth of 35.6%, he added.
The midpoint of the full-year revenue guidance reflects 13.8% growth, missing Street expectations of 14.0%, the analyst stated. "HubSpot is positioned for re-accelerating revenue growth with Q1, as the bottom in recurring revenue growth for the year and current economic cycle." 
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
RBC Capital Markets On HubSpot
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5846fffaee7bf6000154d142/rishi-jaluria">Analyst Rishi Jaluria</a> maintained an Outperform rating, while raising the price target from $825 to $950.
HubSpot reported revenue of $703.2 million, up 21% year-on-year and beating consensus $673.3 million, Jaluria said. Non-GAAP earnings came in at $2.32 per share, higher than consensus of $2.19 per share, he added.
Gross retention remained in the high-80s, while net retention increased to 104%, the analyst stated. While the 2025 guidance does not reflect any AI monetization, management indicated momentum in AI adoption throughout the business, he said.  "All in, HubSpot continues to innovate and execute well, and we think guidance is conservative." 
Oppenheimer On HubSpot
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6006d04ba6fe6f00019855f6/cory-carpenter">Analyst Ken Wong</a> reiterated an Outperform rating, while lifting the price target from $850 to $900.
HubSpot reported strong fourth-quarter results and management spoke positively about "AI interest activating cross-sell activity across Content Hub and Service Hub," Wong said. The company's full-year guidance appears conservative, he added.
Content Hub's net new attach rate rose from 13% to 54% through 2024, the analyst stated. "We see upmarket share gains, wider customer funnel, and further AI utilization as viable sources of incremental growth," he further wrote.
HUBS Price Action: Shares of HubSpot had risen by 5.23% to $826.28 at the time of publication on Thursday.
Read More:<a href="https://www.benzinga.com/25/02/43485175/amd-alphabet-snap-chipotle-and-tesla-why-these-5-stocks-are-on-investors-radars-today"></a> <a href="https://www.benzinga.com/25/02/43697537/robinhood-gilead-sciences-crocs-lincoln-electric-hubspot-ge-healthcare-and-other-big-stocks-moving-higher-on-thursday">Robinhood, Gilead Sciences, Crocs, Lincoln Electric, HubSpot, GE HealthCare And Other Big Stocks Moving Higher On Thursday</a>
Photo: Shutterstock

Analyst Color

Earnings

Earnings Beats

Price Target

Reiteration

Analyst Ratings

Movers

Trading Ideas

HUBS

HubSpot Posts Solid Q4: AI To 'Reinforce Value Of Multi-Cloud Platforms,' Analysts Say

Deep-pocketed investors have adopted a bullish approach towards Confluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CFLT usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 16 extraordinary options activities for Confluent. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 43% leaning bullish and 43% bearish. Among these notable options, 3 are puts, totaling $251,572, and 13 are calls, amounting to $538,455.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $10.0 to $50.0 for Confluent over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Confluent stands at 1412.06, with a total volume reaching 15,300.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Confluent, situated within the strike price corridor from $10.0 to $50.0, throughout the last 30 days.
<h3>Confluent Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739477730_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CFLT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$15.0</td>
<td>$14.8</td>
<td>$14.8</td>
<td>$50.00</td>
<td>$183.5K</td>
<td>8</td>
<td align="right">130</td>
</tr>
<tr>
<td>CFLT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$1.05</td>
<td>$0.9</td>
<td>$1.0</td>
<td>$36.00</td>
<td>$68.0K</td>
<td>4.1K</td>
<td align="right">441</td>
</tr>
<tr>
<td>CFLT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/20/26</td>
<td>$12.9</td>
<td>$12.0</td>
<td>$12.0</td>
<td>$30.00</td>
<td>$66.0K</td>
<td>285</td>
<td align="right">55</td>
</tr>
<tr>
<td>CFLT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$9.4</td>
<td>$9.3</td>
<td>$9.3</td>
<td>$27.00</td>
<td>$58.5K</td>
<td>419</td>
<td align="right">154</td>
</tr>
<tr>
<td>CFLT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$7.2</td>
<td>$6.8</td>
<td>$6.92</td>
<td>$32.00</td>
<td>$54.5K</td>
<td>493</td>
<td align="right">80</td>
</tr>
</tbody>
</table>

<h3>About Confluent</h3>
Confluent Inc is a new category of data infrastructure designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. Its products include Confluent Platform; Connectors; ksqlDB and others. The company generates revenue from the sale of subscriptions and services. Geographically, it derives a majority of its revenue from the United States. The company provides solutions to Financial Services; Insurance; Retail and eCommerce; Automotive; Government and other sectors.
Following our analysis of the options activities associated with Confluent, we pivot to a closer look at the company's own performance.
<h3>Confluent's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 11,128,531, the CFLT's price is down by -4.04%, now at $36.13. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 82 days.</li>
</ul>
<h3>Professional Analyst Ratings for Confluent</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $37.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Barclays has decided to maintain their Overweight rating on Confluent, which currently sits at a price target of $37. 
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Confluent with a target price of $42. 
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Overweight rating for Confluent, targeting a price of $40. 
&#x2A; Consistent in their evaluation, an analyst from Stifel keeps a Buy rating on Confluent with a target price of $40. 
&#x2A; An analyst from Morgan Stanley downgraded its action to Equal-Weight with a price target of $30. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Confluent with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Markets

CFLT

Confluent's Options: A Look at What the Big Money is Thinking

Deep-pocketed investors have adopted a bullish approach towards Eaton Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ETN usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Eaton Corp. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 62% leaning bullish and 37% bearish. Among these notable options, 6 are puts, totaling $390,931, and 2 are calls, amounting to $98,130.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $220.0 to $450.0 for Eaton Corp over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Eaton Corp's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Eaton Corp's significant trades, within a strike price range of $220.0 to $450.0, over the past month.
<h3>Eaton Corp 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739477725_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ETN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$44.9</td>
<td>$42.7</td>
<td>$44.9</td>
<td>$350.00</td>
<td>$130.2K</td>
<td>404</td>
<td align="right">29</td>
</tr>
<tr>
<td>ETN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$44.9</td>
<td>$42.7</td>
<td>$44.8</td>
<td>$350.00</td>
<td>$94.0K</td>
<td>404</td>
<td align="right">50</td>
</tr>
<tr>
<td>ETN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$3.7</td>
<td>$3.7</td>
<td>$3.7</td>
<td>$330.00</td>
<td>$69.9K</td>
<td>1.0K</td>
<td align="right">149</td>
</tr>
<tr>
<td>ETN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$56.3</td>
<td>$55.0</td>
<td>$55.5</td>
<td>$350.00</td>
<td>$49.9K</td>
<td>217</td>
<td align="right">14</td>
</tr>
<tr>
<td>ETN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$6.3</td>
<td>$6.2</td>
<td>$6.2</td>
<td>$220.00</td>
<td>$49.0K</td>
<td>3</td>
<td align="right">10</td>
</tr>
</tbody>
</table>

<h3>About Eaton Corp</h3>
Founded in 1911 by Joseph Eaton, the eponymous company began by selling truck axles in New Jersey. Eaton has since become an industrial powerhouse largely through acquisitions in various end markets. Eaton's portfolio can broadly be divided into two parts: its electrical and industrial businesses. Its electrical portfolio (representing around 70% of company revenue) sells components within data centers, utilities, and commercial and residential buildings, while its industrial business (30% of revenue) sells components within commercial and passenger vehicles and aircraft. Eaton receives favorable tax treatment as a domiciliary of Ireland, but it generates over half of its revenue within the US.
<h3>Where Is Eaton Corp Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 1,943,357, with ETN's price down by -0.88%, positioned at $307.15.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 75 days.</li>
</ul>
<h3>What The Experts Say On Eaton Corp</h3>
A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $365.25.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Melius Research downgraded its rating to Hold, setting a price target of $373. 
&#x2A; Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on Eaton Corp with a target price of $405. 
&#x2A; An analyst from JP Morgan persists with their Overweight rating on Eaton Corp, maintaining a target price of $348. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Equal-Weight rating on Eaton Corp, which currently sits at a price target of $335. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Eaton Corp options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Eaton Corp Unusual Options Activity For February 13

Investors with a lot of money to spend have taken a bullish stance on Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with AMZN, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 100 uncommon options trades for Amazon.com.
This isn't normal.
The overall sentiment of these big-money traders is split between 51% bullish and 34%, bearish.
Out of all of the special options we uncovered, 32 are puts, for a total amount of $3,549,333, and 68 are calls, for a total amount of $6,237,747.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $100.0 to $355.0 for Amazon.com over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Amazon.com's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Amazon.com's whale trades within a strike price range from $100.0 to $355.0 in the last 30 days. 
<h3>Amazon.com Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739477721_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$21.75</td>
<td>$21.65</td>
<td>$21.75</td>
<td>$210.00</td>
<td>$348.0K</td>
<td>15.7K</td>
<td>1.5K</td>
</tr>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$21.85</td>
<td>$21.75</td>
<td>$21.75</td>
<td>$210.00</td>
<td>$339.3K</td>
<td>15.7K</td>
<td>1.5K</td>
</tr>
<tr>
<td>AMZN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$25.55</td>
<td>$25.45</td>
<td>$25.45</td>
<td>$250.00</td>
<td>$269.7K</td>
<td>1.2K</td>
<td>106</td>
</tr>
<tr>
<td>AMZN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$8.2</td>
<td>$8.05</td>
<td>$8.17</td>
<td>$190.00</td>
<td>$163.4K</td>
<td>5.9K</td>
<td>226</td>
</tr>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$8.1</td>
<td>$8.05</td>
<td>$8.05</td>
<td>$245.00</td>
<td>$150.5K</td>
<td>7.1K</td>
<td>352</td>
</tr>
</tbody>
</table>

<h3>About Amazon.com</h3>
Amazon is the leading online retailer and marketplace for third party sellers. Retail related revenue represents approximately 75% of total, followed by Amazon Web Services' cloud computing, storage, database, and other offerings (15%), advertising services (5% to 10%), and other the remainder. International segments constitute 25% to 30% of Amazon's non-AWS sales, led by Germany, the United Kingdom, and Japan.
<h3>Present Market Standing of Amazon.com</h3>
<ul>
<li>With a volume of 18,245,341, the price of AMZN is up 0.39% at $229.82. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 75 days.</li>
</ul>
<h3>What Analysts Are Saying About Amazon.com</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $266.6.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Citigroup has decided to maintain their Buy rating on Amazon.com, which currently sits at a price target of $273. 
&#x2A; An analyst from DA Davidson has decided to maintain their Buy rating on Amazon.com, which currently sits at a price target of $280. 
&#x2A; An analyst from Needham has revised its rating downward to Buy, adjusting the price target to $250. 
&#x2A; An analyst from Needham has revised its rating downward to Buy, adjusting the price target to $250. 
&#x2A; Consistent in their evaluation, an analyst from Canaccord Genuity keeps a Buy rating on Amazon.com with a target price of $280. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Amazon.com options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

AMZN

Behind the Scenes of Amazon.com's Latest Options Trends

Crocs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CROX#NASDAQ">CROX</a>) has outperformed the market over the past 5 years by 10.78% on an annualized basis producing an average annual return of 23.35%. Currently, Crocs has a market capitalization of $6.37 billion. 
Buying $1000 In CROX: If an investor had bought $1000 of CROX stock 5 years ago, it would be worth $2,856.02 today based on a price of $109.30 for CROX at the time of writing.
<h3>Crocs's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739477721_0_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

CROX

Here's How Much $1000 Invested In Crocs 5 Years Ago Would Be Worth Today

CHEF

Chefs' Warehouse shares are trading higher after BMO Capital, Benchmark and UBS raised their respective price targets on the stock

Shares of AppLovin Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) were climbing in early trading on Thursday, after the company reported <a href="https://www.benzinga.com/news/earnings/25/02/43676556/applovin-stock-soars-on-q4-earnings-revenue-beat-eps-beat-strong-guidance-and-more">upbeat fourth-quarter results</a>.
The company reported its quarterly results amid an <a href="https://www.benzinga.com/earnings">positive earnings season</a>. Here are some key analyst takeaways.
BofA Securities On AppLovin
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/627d2395766cb1000166ef56/omar-dessouky">Analyst Omar Dessouky</a> reaffirmed a Buy rating, while raising the price target from $375 to $580.
The magnitude of AppLovin's fourth-quarter beat was "completely unexpected," Dessouky said in a note. eCommerce is estimated to have contributed around $100 million in revenues in the quarter in addition to the 7% sequential growth in net revenue from mobile game advertisers, he added.
The high end of management's revenue guidance for the first quarter reflects 5% sequential growth, "driven by self-learning in both eCommerce and Gaming models," the analyst stated. "APP&#8217;s reported financial performance supports the notion that eCommerce ads work and that revenue could scale to penetrate 10mn+ merchants globally," he further wrote.
JPMorgan On AppLovin
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6006d04ba6fe6f00019855f6/cory-carpenter">Analyst Cory Carpenter</a> reiterated a Neutral rating, while lifting the price target from $325 to $475.
AppLovin's advertising revenue growth accelerated from 17% sequentially in the previous quarter to 20% in the fourth quarter and came in significantly higher than the guidance of 4%-5%, Carpenter said. Adjusted EBITDA of $848 million represented 78% year-on-year growth and beat the guidance of $740 million to $760 million, he added.
"APP also noted successful early pilots in verticals beyond e-commerce such as fintech, insurance, automotive, and healthcare," the analyst wrote. Management guided to revenues of $1,355 million to $1,385 million, up 29% year-on-year as well as adjusted EBITDA of $855 million to $885 million, up 59%, well above consensus estimates of $1,319 million and $794 million, respectively, he stated.
Benchmark On AppLovin
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5935519f85b07a0001c0bc58/mike-hickey">Analyst Mike Hickey</a> maintained a Buy rating, while raising the price target from $375 to $525.
AppLovin reported 73% year-on-year in advertising revenue growth, Hickey said. The company's first-quarter revenue and AEBITDA guidance came 4% and 10% above consensus, respectively, "fueled by AI-driven ad optimization, non-gaming expansion, and self-serve advertising tools," he added.
"AppLovin is undergoing a strategic transformation, shifting from a gaming-centric ad platform to a pure-play adtech leader with a focus on AI-driven advertising and automation," the analyst wrote. The company's robust performance in the fourth quarter "underscores its ability to scale profitably." 
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Piper Sandler On AppLovin
Analyst James Callahan reaffirmed an Overweight rating, while raising the price target from $400 to $575.
AppLovin continues to execute well across its gaming and non-gaming verticals, while the latter is no longer limited to eCommerce, Callahan said. The company should witness "multiple years of revenue tailwinds from new verticals," he added.
AppLovin announced its plans to sell off the lower-margin Apps segment, "which should simplify the story," the analyst stated. "Management reaffirmed that E-Commerce can be material in 2025," he wrote.  
Goldman Sachs On AppLovin
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587e33195064ed000173030b/eric-sheridan">Analyst Eric Sheridan</a> reiterated a Neutral rating, while lifting the price target from $335 to $500.
The company reported strong operating results and announced the divestiture of its apps (mobile gaming) business, which is likely to close in the second quarter, Sheridan said.
"The company still sees technological advancements (driven by AI and the continued improvements in their AXON 2.0 platform) as driving multiple initiatives for 2025 that can widen the advertiser base, deepen advertiser budget growth, improve self-serve dynamics and result in more ads personalization over the medium/long-term," the analyst wrote.
Oppenheimer On AppLovin
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6012b214a6fe6f0001bd7e3c/martin-yang">Analyst Martin Yang</a> maintained an Outperform rating, while raising the price target from $480 to $560.
AppLovin has decided to expand beyond ecommerce, Yang said.
"Its adtech solution works well not only for mid-market e-commerce brands, but also for companies in fintech, healthcare, automotive, and insurance, which have seen strong results in the pilot," the analyst wrote. The company will be rolling out a self-service dashboard powered by AI agents this year, "which will allow non-game business to scale faster across industries," he added.
Needham On AppLovin
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587635595064ed000140010c/scott-berg">Analyst Bernie McTernan</a> reaffirmed a Hold rating on the stock.
AppLovin generated advertising revenue "at elevated levels" for two consecutive quarters, with 17.5% growth in the third and 19.7% in the fourth quarter, McTernan said. Its ad revenue growth was "driven by underlying model improvements from the model getter smart, engineering improvements on the models and new verticals revenue helping to drive seasonal strength" 
The ad spend from new verticals in the fourth quarter suggest that the pilot program is "off to a strong start," the analyst stated. "The company is working on a gen-AI enabled self service platform that should accelerate new verticals revenue." 
APP Price Action: Shares of AppLovin had risen by 23.26% to $468.79 at the time of publication on Thursday.
Read More:<a href="https://www.benzinga.com/25/02/43485175/amd-alphabet-snap-chipotle-and-tesla-why-these-5-stocks-are-on-investors-radars-today"></a> <a href="https://www.benzinga.com/markets/equities/25/02/43649078/shopify-secures-12-of-us-e-commerce-pie-as-reebok-champion-and-warner-music-join-platform"> Applovin Emerges As Nasdaq 100&#8217;s Dark Horse In A Market Fixated On Nvidia, Tesla, Palantir</a>
Photo: Shutterstock

AppLovin's Stock Rallies After Solid Q4 Growth, Underscores Ability To Scale Profitably, Analysts Say

SHOO

Steven Madden shares are trading higher after the company announced that it will acquire UK-based Kurt Geiger

On Wednesday, 10x Genomics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXG#NASDAQ">TXG</a>) reported a fourth-quarter EPS loss of $(0.40), missing the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus estimate of $(0.30)</a>.
The single-cell and spatial biology company reported quarterly sales of $165.02 million, down 10% year over year, beating the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n43674610/10x-genomics-reports-fourth-quarter-and-full-year-2024-financial-results-and-provides-outlook-for-" rel="noreferrer noopener">consensus of $159.39 million</a>.
Gross margin was 67% for the fourth quarter of 2024 compared to 63% a year ago, primarily due to product mix changes.
10x Genomics' instruments sales fell to $24.35 million from $38.4 million a year ago. This included $10.93 million from Chromium instruments and $13.43 million from Spatial instruments.
Consumables sales decreased from $140.31 million to $133.53 million. Of this, Chromium consumables accounted for $97.74 million, and Spatial consumables generated $35.79 million.
Additionally, services revenue experienced a growth from $5.27 million to $7.14 million.
Guidance: 10x Genomics forecasts fiscal year 2025 sales of $610 million-$630 million, lower than the consensus of $631.14 million. At the midpoint, this guidance implies double-digit growth for both Chromium reactions and overall spatial revenue.
William Blair says the management noted that its guidance does not anticipate any improvements in the macro environment and contemplates a roughly $7 million impact from <a target="_blank" href="https://www.benzinga.com/general/biotech/25/02/43618745/us-states-sue-national-institutes-of-health-over-4-billion-annual-cut-in-biomedical-research-grant-budget" rel="noreferrer noopener">NIH funding uncertainties</a>.
Analyst Reaction:
<ul>
<li>William Blair notes that 10x has been improving its sales strategy and market position in recent quarters.</li>
<li>Although these changes have hurt profits and are expected to continue doing so through at least early 2025, analyst Matt Larew writes that they are necessary for long-term growth.</li>
<li>The company's commercial reorganization should be finished by mid-2025, and the pricing challenges from the GEM-X transition are expected to ease by the fourth quarter.</li>
<li>William Blair keeps the <a href="https://www.benzinga.com/quote/TXG/analyst-ratings" target="_blank" rel="noreferrer noopener">Market Perform rating</a>.</li>
<li>Leerink Partners analyst Mike Kratky downgrades 10x Genomics from Outperform to Market Perform rating and lowers the price target from $25 to $12.</li>
<li>Stifel analyst Daniel Arias maintains 10x Genomics with a Buy rating and lowers the price target from $21 to $18.</li>
<li>UBS analyst Dan Leonard maintains 10x Genomics with a Neutral rating and has lowered the price target from $20 to $14.</li>
<li>JP Morgan analyst Rachel Vatnsdal maintains the Neutral rating but cut the price target from $14 to $12.</li>
</ul>
Price Action: TXG stock is down 6% at $11.28 at the last check on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/43694382/consumer-giant-unilever-warns-on-slower-start-to-2025-ice-cream-spin-off-moves-forward-with-amsterdam-incorporation" target="_blank" rel="noreferrer noopener">Consumer Giant Unilever Warns On Slower Start To 2025, Ice Cream Spin-Off Moves Forward With Amsterdam Incorporation</a></li>
</ul>

Guidance

Health Care

Life Science Company 10x Genomics Struggles With Profitability, Analyst Says 2025 Guidance Bakes In NIH Funding Uncertainties

BPMC

Blueprint Medicines shares are trading lower after company reported worse-than-expected Q4 EPS results.

Shares of Westinghouse Air Brake Technologies Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAB#NYSE">WAB</a>) got crushed yesterday after missing earnings. But they may be about to reverse and move higher.
The shares are oversold and at support. This is why Westinghouse is our <a href="https://www.benzinga.com/topic/stock-of-the-day">Stock of the Day</a>.
As you can see on the chart, the $187 level has been support for the shares since October.
Support is a large group of investors or traders who are looking to buy shares at, or close to the same price. At support levels, there is enough demand to absorb all of the supply of shares that are for sale in a market.
This is why selloffs end or at least pause when they reach them.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/02/43692996/inflation-fears-mount-as-producer-prices-soar-to-35-put-fed-interest-rate-cut-on-ice">Inflation Fears Grow As Producer Prices Rise To 3.5%, Clouding Fed Interest Rate Cut Hopes</a>
Sometimes stocks rally after they reach a support level. That's what happened with Westinghouse in December and January and it may be about to happen again.
Stocks can rally off of support levels because of buyer's anxiety. Sometimes buyers can become anxious. They know that whoever wants to sell is going to go to whoever is willing to pay the highest price. They are afraid they will be outbid and they don't want to miss the trade.
So, they increase the prices they are willing to pay. Other anxious buyers see this and decide to do the same thing. This can result in a bidding war or snowball effect that pushes the price higher.
In addition, the stock is very oversold.
The red line on the chart below is two standard deviations below the 20-day moving average. Statistics and probability theory suggest that 95% of trading should be within two standard deviations of the mean. Since WAB exceeded this threshold to the downside, it will get the attention of trading algorithms and programs that are driven by statistics.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="550" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13150004/117-1024x550.png" alt="" class="wp-image-781889" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13150004/117-1024x550.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13150004/117-300x161.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13150004/117-768x413.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13150004/117.png 1524w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
They will be anticipating a reversion to the mean or a move higher. This will draw them into the market as buyers, and they could put upward pressure on the stock.
Shares of Westinghouse are at support while being oversold. These dynamics could set the stage for a move higher.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43703014/robert-f-kennedy-confirmed-as-trump-secretary-of-health">Robert F. Kennedy, Vaccine Skeptic, Confirmed As Trump&#8217;s Secretary Of Health: Health Care Stocks To Watch</a></li>
</ul>
Image: Shutterstock

Technicals

Stock Of The Day: Is Westinghouse About To Rally?

Most people will not notice the importance of this week. They will be far too busy talking about things like AI eating the world, China taking over the government, and Elon Musk ascending to the Interplanetary throne to notice. 
The media will not be much help. They will be busy covering the vast conspiracy surrounding the President&#8217;s bathroom schedule and the whereabouts of Scaramucci&#8217;s mom.
The instant experts of the Internet will be far too busy touting the new nuclear plants that will fit in your pocket and allow you to mine Bitcoin and develop a personal AGI program on the go. The fancier models will apparently have an adapter that allows you to mount the reactor to your dash and simultaneously power your vehicle&#8217;s onboard entertainment system.
First, and most importantly, pitchers and catchers report this week. It is, as the saying goes, huge. I already have my tickets to catch the Orioles when they come to town, and I am ready for baseball season.
This week is also the deadline for 13F filings at the SEC. These handy documents contain all the stocks owned by the nation&#8217;s money managers, hedge funds, and other big-money types.
Comparing this quarter&#8217;s filings to the last gives us a picture of what big money (only some of which is Smart Money) was buying and selling in the final quarter of 2024. The media and instant experts will cover the duplicate half-dozen filings they always cover. We will cover the ones our research indicates are highly likely to help us locate stock ideas that deliver the outsized returns we seek.
One of the investors I have tracked for over a decade filed early this quarter. PL Capital has been investing in bank stocks for a long time with enormous success. When the occasion calls for it, the firm has taken an activist approach to bank stock investing with outstanding results for those of us who piggybacked their efforts.
Thanks to pro-business, no-regulation, and low-tax administration, bank stocks are positioned to be the leading sector for 2025. Relaxing the bank M&amp;A rules is going to set off a tsunami of pent-up demand for buyers and sellers alike.
I could go into a long explanation and examination of each stock, but it will not change any minds. You either understand why banks are an extraordinary opportunity right now or you do not care about banks.
Here are the top three banks that PL Capital has been buying recently:
F.N.B. Corp (Ticker: FNB) is a Pittsburgh-based bank with 350 banking offices throughout Pennsylvania, Ohio, Maryland, West Virginia, North Carolina, South Carolina, Washington, D.C., and Virginia. FNB already reported earnings and is firing on all cylinders. Deposits and demand both grew, and tangible book value was up double digits year over year. The bank has plenty of capital and the loan portfolio is solid.
BankFinancial Corporation (Ticker: BFIN) has 19 branches in the Chicago Metropolitan area. The bank is well-capitalized and has a solid loan portfolio. Given its size and market, I would be less than surprised to see a larger bank that wanted to expand in the Chicago metro market make an offer for this bank at some point in 2025.
Franklin Financial (Ticker: FRAF) has 24 branches in South Central Pennsylvania and Northwestern Maryland. Franklin has a pristine loan portfolio, sufficient capital, and trades at a reasonable valuation. Investors who accumulated the stock on pullbacks should do very well over the next year.
All three are in excellent financial shape, have strong loan portfolios, and trade at attractive valuations.
Keeping with the week&#8217;s most important news, I noticed that media mogul John Malone shared my excitement at baseball&#8217;s return. In January, he acquired shares of Atlanta Braves Holdings (Ticker: BATRK) worth over $3 million, adding to his substantial stake in the baseball team. The Braves are one of the most popular teams in baseball, and last year, they drew over 3 million fans to Truist Park. Braves games are a staple on TV and radio stations across the Southeastern United States. The team will be good again this year and is the early favorite to win their division and make the playoffs in 2025.
Atlanta Braves Holdings also owns a mixed-use development around the stadium with retail, residential, office, hotel, and entertainment opportunities known as The Battery Atlanta. The shops and restaurants are a source of year-round revenue and appear to be undervalued by the current stock price.
I have hit (pardon the too-easy pun) home runs with shares of the Cleveland Indians and Boston Celtics in my career, and every time we have a bad market or the Braves suffer a losing streak, I add to my Braves Holdings position hoping lightning strikes a third time.

Opinion

BATRK

BFIN

FRAF

C-Suite Buy of the Week: Bank Stocks on the Brink of a Home Run

INTC

Some Upcoming Chips Act Payments To Be Delayed

Across the recent three months, 11 analysts have shared their insights on Diamondback Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>), expressing a variety of opinions spanning from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Diamondback Energy, revealing an average target of $219.09, a high estimate of $256.00, and a low estimate of $190.00. Highlighting a 0.66% decrease, the current average has fallen from the previous average price target of $220.55. 
<img src="https://www.benzinga.com/files/images/story/2025/1739476859_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Diamondback Energy. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$216.00</td>
<td>$212.00</td>
</tr>
<tr>
<td>John Freeman</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$256.00</td>
<td>$237.00</td>
</tr>
<tr>
<td>Scott Hanold</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$210.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Arun Jayaram</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$195.00</td>
<td>$191.00</td>
</tr>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$236.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>Doug Leggate</td>
<td>Wolfe Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$190.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$232.00</td>
<td>$252.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$219.00</td>
<td>$218.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$207.00</td>
<td>$219.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$212.00</td>
<td>$235.00</td>
</tr>
<tr>
<td>John Freeman</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$237.00</td>
<td>$232.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Diamondback Energy. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Diamondback Energy compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Diamondback Energy's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into Diamondback Energy's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/FANG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Diamondback Energy analyst ratings.</a>
<h2>Unveiling the Story Behind Diamondback Energy</h2>
Diamondback Energy is an independent oil and gas producer in the United States. The company operates exclusively in the Permian Basin. At the end of 2023, the company reported net proven reserves of 2.2 billion barrels of oil equivalent. Net production averaged about 448,000 barrels per day in 2023, at a ratio of 59% oil, 21% natural gas liquids, and 20% natural gas.
<h3>Unraveling the Financial Story of Diamondback Energy</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Positive Revenue Trend: Examining Diamondback Energy's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 13.03% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Energy sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 24.91%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 2.4%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Diamondback Energy's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 1.3%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a below-average debt-to-equity ratio of 0.35, Diamondback Energy adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>What Are Analyst Ratings?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FANG

11 Analysts Have This To Say About Diamondback Energy

In the latest quarter, 4 analysts provided ratings for QuidelOrtho (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QDEL#NASDAQ">QDEL</a>), showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $49.75, a high estimate of $61.00, and a low estimate of $43.00. A 1.15% drop is evident in the current average compared to the previous average price target of $50.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1739476846_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive QuidelOrtho. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Conor McNamara</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$61.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>John Sourbeer</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$45.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Patrick Donnelly</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$50.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>Tycho Peterson</td>
<td>Jefferies</td>
<td>Announces</td>
<td>Hold</td>
<td>$43.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to QuidelOrtho. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of QuidelOrtho compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for QuidelOrtho's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into QuidelOrtho's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/QDEL/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on QuidelOrtho analyst ratings.</a>
<h2>Get to Know QuidelOrtho Better</h2>
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.
<h3>Unraveling the Financial Story of QuidelOrtho</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: QuidelOrtho's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2024, the company experienced a revenue decline of approximately -2.27%. This indicates a decrease in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: QuidelOrtho's net margin excels beyond industry benchmarks, reaching -2.74%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): QuidelOrtho's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -0.63% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): QuidelOrtho's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of -0.29%, the company showcases efficient use of assets and strong financial health.
Debt Management: QuidelOrtho's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.86.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

QDEL

Where QuidelOrtho Stands With Analysts

5 analysts have expressed a variety of opinions on Everus Construction Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECG#NYSE">ECG</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Everus Construction Group, presenting an average target of $76.0, a high estimate of $85.00, and a low estimate of $67.00. Holding firm without variation, the current average remains at the previous average price target. 
<img src="https://www.benzinga.com/files/images/story/2025/1739476838_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The standing of Everus Construction Group among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brian Brophy</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$67.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Brian Brophy</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$85.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Ian Zaffino</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$80.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Brian Brophy</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$78.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Ian Zaffino</td>
<td>Oppenheimer</td>
<td>Announces</td>
<td>Outperform</td>
<td>$70.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Everus Construction Group. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Everus Construction Group compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Everus Construction Group's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Everus Construction Group's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ECG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Everus Construction Group analyst ratings.</a>
<h2>About Everus Construction Group</h2>
Everus Construction Group Inc is a construction solutions provider, offering specialty contracting services to a diverse set of end markets across the U.S. It operates across two segments, Electrical &amp; Mechanical (E&amp;M) and Transmission &amp; Distribution (T&amp;D), and delivers services through its subsidiaries. It generates the majority of revenue from the Electrical &amp; Mechanical segment which offers a wide variety of specialty contracting services, including construction and maintenance of electrical and communication wiring, fire suppression systems, and mechanical piping and services, to customers in both the public and private sectors. Its T&amp;D segment serves electric and natural gas utility customers, as well as customers in the transportation end market, in the West and Midwest regions.
<h3>Everus Construction Group's Financial Performance</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Everus Construction Group's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 6.07% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: Everus Construction Group's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.49% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Everus Construction Group's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 9.79% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Everus Construction Group's ROA stands out, surpassing industry averages. With an impressive ROA of 3.27%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Everus Construction Group's debt-to-equity ratio is below the industry average. With a ratio of 0.63, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Breaking Down Everus Construction Group: 5 Analysts Share Their Views

Financial giants have made a conspicuous bearish move on United States Steel. Our analysis of options history for United States Steel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) revealed 20 unusual trades.
Delving into the details, we found 45% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $357,165, and 14 were calls, valued at $464,689.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $35.0 and $45.0 for United States Steel, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in United States Steel's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to United States Steel's substantial trades, within a strike price spectrum from $35.0 to $45.0 over the preceding 30 days.
<h3>United States Steel 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739476833_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>X</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$10.0</td>
<td>$8.35</td>
<td>$8.45</td>
<td>$42.00</td>
<td>$168.9K</td>
<td>759</td>
<td align="right">200</td>
</tr>
<tr>
<td>X</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$7.65</td>
<td>$6.2</td>
<td>$7.65</td>
<td>$45.00</td>
<td>$51.2K</td>
<td>3.5K</td>
<td align="right">77</td>
</tr>
<tr>
<td>X</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$4.65</td>
<td>$4.3</td>
<td>$4.45</td>
<td>$36.00</td>
<td>$44.5K</td>
<td>364</td>
<td align="right">21</td>
</tr>
<tr>
<td>X</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$5.9</td>
<td>$4.4</td>
<td>$4.4</td>
<td>$39.00</td>
<td>$43.5K</td>
<td>831</td>
<td align="right">104</td>
</tr>
<tr>
<td>X</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$4.2</td>
<td>$4.15</td>
<td>$4.18</td>
<td>$38.00</td>
<td>$41.6K</td>
<td>1.4K</td>
<td align="right">116</td>
</tr>
</tbody>
</table>

<h3>About United States Steel</h3>
United States Steel Corp operates in the United States but also has a steelmaking capacity in Slovakia. The company's operating segments include North American Flat-Rolled (Flat-Rolled), Mini Mill, U. S. Steel Europe (USSE), and Tubular Products (Tubular). The Flat-Rolled segment includes U. S. Steel's integrated steel plants and equity investees in North America involved in the production of slabs, strip mill plates, sheets, and tin mill products, as well as all iron ore and coke production facilities in the United States. It serves North American customers in the service center, conversion, transportation, construction, container, and appliance, and electrical markets.
<h3>Current Position of United States Steel</h3>
<ul>
<li>With a volume of 3,644,149, the price of X is down -0.82% at $38.23. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 77 days.</li>
</ul>
<h3>What The Experts Say On United States Steel</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $39.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Morgan Stanley lowers its rating to Equal-Weight with a new price target of $39. 
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on United States Steel with a target price of $40. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for United States Steel with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Comments

M&A Research Institute

M&A Research Institute (MAARF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga